Immatics at the Cell Transfer Congress (Oct 10-11) in London, UK

| News

Examining the latest advances in CAR and TCR therapies

Meet Immatics at the Cell Transfer Congress and get an update on TCR-T based approaches and XPRESIDENT®, our leading platform for the discovery of novel targets for all types of TCR-T therapy:

Thursday, Oct 10 (Day 1)

Morning Refreshments/ Poster Presentations

Beyond CD19: Multi-targeted adoptive cell therapy for solid tumors

Speaker: Steffen Walter, CSO Immatics US

More information about the Cell Transfer Congress here.

Press Contact

Anja Heuer

Corporate Communications,
Immatics Biotechnologies GmbH

+49 89 540 415 606

Go back

We use cookies to ensure that we give you the best experience on our website.